Source: Business Wire

Press Release: McMaster-Carr : Fuzionaire Diagnostics Enters Agreement with McMaster University to Expand Capabilities in Developing Theranostic Radiopharmaceuticals

THE WOODLANDS, Texas--(BUSINESS WIRE)--Fuzionaire Diagnostics Enters Agreement with McMaster University to Expand Capabilities in Developing Theranostic Radiopharmaceuticals

Read full article »
Est. Annual Revenue
$1.0-5.0B
Est. Employees
1.0-5.0K
CEO Avatar

CEO

Jay Delaney

CEO Approval Rating

71/100

Read more